Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Current Opinion in Rheumatology|January 19, 2016
Osteoporosis and osteoarthritis: shared mechanisms and epidemiologyPiet P Geusens, Joop P van den Bergh
Nature Reviews. Rheumatology|September 19, 2012
Bone: New guidelines for multistep fracture prevention in menPiet P M Geusens, Joop P van den Bergh
Nature Reviews. Rheumatology|January 18, 2012
Osteoporosis, frailty and fracture: implications for case finding and therapyJoop P van den Bergh, Tineke A van Geel, Piet P Geusens
Archives of Osteoporosis|October 4, 2022
A model-based cost-effectiveness analysis of fracture liaison services in ChinaNannan Li, Lei Si, Annelies Boonen, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 24, 2016
Perceived Physical Activity Decline as a Mediator in the Relationship Between Pain Catastrophizing, Disability, and Quality of Life in Patients with Painful Diabetic NeuropathyCharlotte C Geelen, Hanne P Kindermans, Joop P van den Bergh, et al.
Best Practice & Research. Clinical Rheumatology|September 25, 2019
Fracture liaison programsPiet Geusens, Sandrine P G Bours, Caroline E Wyers, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 11, 2024
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison servicesLieke Maas, Annelies Boonen, Nannan Li, et al.
Journal of the American Medical Directors Association|December 17, 2019
The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort StudyShahab Abtahi, Andrea M Burden, Piet Geusens, et al.
Calcified Tissue International|January 10, 2016
Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD MeasurementsFreek J B Lötters, Joop P van den Bergh, Frank de Vries, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2014
Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronateSantiago Palacios, Irene Agodoa, Sydney Bonnick, et al.
Pageof 10